AVROBIO, Inc.

Home » AVROBIO, Inc.

IPO

AVROBIO, Inc.

We are a clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.

Symbol

AVRO

Price Range
$16.00 - $18.00

Final Shares
4,400,000

Anticipated Date
TBD

Underwriters
MORGAN STANLEY, COWEN, WELLS FARGO SECURITIES, WEDBUSH PACGROW

To view the prospectus for AVROBIO, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253